Nonoxidized MXene Quantum Dots Prepared by Microexplosion Method for Cancer Catalytic Therapy
Nanocatalysts based on Fenton or Fenton‐like reactions for amplification of intracellular oxidative stress has become a frontier research area of tumor precise therapy. However, the major translational challenges are low catalytic efficiency, poor biocompatibility, and even potential toxicities. Her...
Gespeichert in:
Veröffentlicht in: | Advanced functional materials 2020-06, Vol.30 (24), p.n/a |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Nanocatalysts based on Fenton or Fenton‐like reactions for amplification of intracellular oxidative stress has become a frontier research area of tumor precise therapy. However, the major translational challenges are low catalytic efficiency, poor biocompatibility, and even potential toxicities. Here, a Ti‐based material with excellent biocompatibility is proposed for cancer treatment. The nonoxidized MXene‐Ti3C2Tx quantum dots (NMQDs‐Ti3C2Tx) are successfully prepared by a self‐designed microexplosion method. Surprisingly, it has an apparent inhibitory and killing effect on cancer cells, and excellent biocompatibility with normal cells. Moreover, the suppression rate of NMQDs‐Ti3C2Tx on xenograft tumor models can reach 91.9% without damaging normal tissues. Mechanistically, the Ti3+ of NMQDs‐Ti3C2Tx can react with H2O2 in the tumor microenvironment and high‐efficiently produce excessive toxic hydroxyl radicals to increase tumor microvascular permeability to synergistically kill cancer cells. This work should pave the way for tumor catalytic therapy applications of Ti‐based material as a promising and safer route.
For nanocatalytic treatment of tumors, a safer strategy is proposed: using titanium‐based materials with good biocompatibility for tumor treatment. The prepared nonoxidized MXene‐Ti3C2Tx quantum dots show satisfactory antitumor effect, proving the feasibility of this strategy. Although inoculated tumor cells are the fastest‐growing HeLa cells, the tumor suppression rate is 91.9%, without affecting the health of mice. |
---|---|
ISSN: | 1616-301X 1616-3028 |
DOI: | 10.1002/adfm.202000308 |